British Liver Trust. The alarming impact of liver disease in the UK. 2019. Available from: https://britishlivertrust.org.uk/wp-content/uploads/The-alarming-impact-of-liver-disease-FINAL-June-2019.pdf. Accessed 4 Nov 2019.

British Liver Trust. Becoming a living liver donor. Why do we need more living liver donors? Available from: https://britishlivertrust.org.uk/becoming-a-living-liver-donor. Accessed 22 Nov 2019.

Durand F, Renz J, Alkofer B, Burra P, Clavien P, Porte R, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transplant. 2008;14(12):1694–707.

Article  Google Scholar 

Parekh S, Anania F. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007;132(6):2191–207.

Article  CAS  PubMed  Google Scholar 

Chu MJ, Dare AJ, Phillips AR, Bartlett AS. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg. 2015;19(9):1713–24.

Article  PubMed  Google Scholar 

Spitzer A, Lao O, Dick A, Bakthavatsalam R, Halldorson J, Yeh M, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transplant. 2010;16(7):874–84.

Article  Google Scholar 

Nativ N, Maguire T, Yarmush G, Brasaemle D, Henry S, Guarrera J, et al. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant. 2012;12(12):3176–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

NHS Blood and Transfusion (NHSBT). Annual report on liver transplantation: report for 2014/2015. 2016. Available from: http://www.odt.nhs.uk/pdf/organ_specific_report_liver_2014.pdf. Accessed 22 Nov 2019.

Dyson J, Anstee Q, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2013;5(3):211–8.

Article  PubMed  PubMed Central  Google Scholar 

NHS Digital. Statistics on Obesity, Physical Activity and Diet: England 2015. 2015. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/statistics-on-obesity-physical-activity-and-diet/statistics-on-obesity-physical-activity-and-diet-england-2015. Accessed 4 Nov 2019.

NHS Blood and Transfusion (NHSBT). Annual report on liver transplantation. 2019. Available from: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf. Accessed 22nd Nov 2019.

Brockmann J, Reddy S, Coussios C, Pigott D, Guirriero D, Hughes D, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg. 2009;250(1):1–6.

Article  PubMed  Google Scholar 

Ravikumar R, Jassem W, Mergental H, Heaton N, Mirza D, Perera MTPR, et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transplant. 2016;16(6):1779–87.

Article  CAS  PubMed  Google Scholar 

Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50–6.

Article  CAS  PubMed  Google Scholar 

Watson CJE, Kosmoliaptsis V, Pley C, Randle L, Fear C, Crick K, et al. Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018;18(8):2005–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ceresa CDL, Nasralla D, Watson CJE, Butler AJ, Coussios CC, Crick K, et al. Transient Cold storage prior to normothermic liver perfusion may facilitate adoption of a novel technology. Liver Transplant. 2019;25(10):1503–13.

Article  Google Scholar 

Mergental H, Mirza D, Laing R, Kirkham A, Perera MTP, Boteon Y, et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun. 2020;11(1):2939. https://doi.org/10.1038/s41467-020-16251-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serafín A, Roselló-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol. 2002;161(2):587–601.

Article  PubMed  PubMed Central  Google Scholar 

Mosbah I Ben, Roselló-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, et al. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. Liver Transplant. 2010;16(2):163-71.

Laurens M, Scozzari G, Patrono D, St-Paul MC, Gugenheim J, Huet PM, et al. Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver. Liver Transplant. 2006;12(2):217–25.

Article  Google Scholar 

Boteon Y, Boteon A, Attard J, Mergental H, Mirza D, Bhogal R, et al. Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies A systematic review. Am J Transplant. 2018;18(10):2384–99.

Article  PubMed  Google Scholar 

Nagrath D, Xu H, Tanimura Y, Zuo R, Berthiaume F, Avila M, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng. 2009;11(4–5):274–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamieson RW, Zilvetti M, Roy D, Hughes D, Morovat A, Coussios CC, et al. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation. 2011;92(3):289–95.

Article  PubMed  Google Scholar 

Liu Q, Nassar A, Buccini L, Iuppa G, Soliman B, Pezzati D, et al. Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transplant. 2018;24(2):233–45.

Article  Google Scholar 

Banan B, Watson R, Xu M, Lin Y, Chapman W. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers. Liver Transplant. 2016;22(7):979–93.

Article  Google Scholar 

Raigani S, Carroll C, Cronin S, Pendexter C, Rosales I, Yarmush M, Uygun K, Yeh H. Defatting steatotic rat livers during ex situ normothermic perfusion improves lactate clearance and bile quality [abstract]. Am J Transplant. 2019;19(Suppl 3). American Transplant Congress; 2019 June 1-5; Boston, Massachusetts.

Boteon YL, Attard J, Boteon APCS, Wallace L, Reynolds G, Hubscher S, et al. Manipulation of lipid metabolism during normothermic machine perfusion: effect of defatting therapies on donor liver functional recovery. Liver Transplant. 2019;25(7):1007–22.

Article  Google Scholar 

Raigani S, Markmann JF, Yeh H. Rehabilitation of discarded steatotic livers using ex situ normothermic machine perfusion: a future source of livers for transplantation. Liver Transplant. 2019;25(7):991–2.

Article  Google Scholar 

Ceresa C, Nasralla D, Neil D, Mergental H, Jassem W, Butler A, et al. A histological and biochemical assessment of steatotic livers undergoing normothermic machine perfusion [abstract]. Transpl Int. 2017;30(Suppl 2):43.OS106. 18th Congress of the European Society for Organ Transplantation; 2017 Sep 24-27; Barcelona, Spain.

Boteon YL, Wallace L, Boteon APCS, Mirza DF, Mergental H, Bhogal RH, et al. An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells. PLoS One. 2018;13(7): e0201419.

Article  PubMed  PubMed Central  Google Scholar 

Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci. 2000;97:7500–7502.

Pollock C, Rodriguez O, Martin P, Albanese C, Li X, Kopelovich L, et al. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. PPAR Res. 2010:1–12.

Ceresa C. Novel approaches in optimising steatotic livers for transplantation [DPhil]. The University of Oxford; 2018.

Bambauer R, Bambauer C, Lehmann B, Latza R, Schiel R. LDL-apheresis: technical and clinical aspects. Sci World J. 2012;2012:1–19.

Article  Google Scholar 

Reuter SE, Evans AM. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects Clinical Pharmacokinetics. Clin Pharmacokinet. 2012;51:553–72.

Article  CAS  PubMed  Google Scholar 

Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A. The effect of L-carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2016;17:970–6.

Article  CAS  PubMed  Google Scholar 

Stefanutti C, Vivenzio A, Lucani G, Di Giacomo S, Lucani E. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia. Clin Ter. 1998;149(2):115–9.

CAS  PubMed  Google Scholar 

Fernandez C, Proto C. L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review. Clin Ter. 1992;140(4):353–77.

CAS  PubMed  Google Scholar 

Koşan C, Sever L, Arisoy N, Çalisşkan S, Kasapçopur Ö. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol. 2003;18(11):1184–8.

Article  PubMed  Google Scholar 

Harper P, Elwin CE, Cederblad G. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol. 1988;35(5):555–62.

Article  CAS  PubMed  Google Scholar 

Bach AC, Schirardin H, Sihr MO, Storck D. Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabete Metab. 1983;9(2):121–4.

CAS  PubMed  Google Scholar